Yes...perhaps not necessarily focused entirely on DMOAD but certainly as a remarkable observation.
Take a look at this post:
https://hotcopper.com.au/threads/the-phd-no-and-the-dmoad-magic-of-ipps.5813276/
Specifically there was a study on canines (I've called it Study 2 in the post above).
An example quote was:
"...the findings of this study confirmed PPS as a novel suitable alternative chondroinductive factor to known chondrocytic growth factors that may offer a solution to the inherent challenges faced in cartilage tissue regeneration and repair of small OA cartilage lesions."
Chrondoinductive factor offering a solution in cartilage tissue regeneration was probably a big clue for us investors.
Another example without spending too much time digging was the experiment with Donkeys...the show me theMozzMoney quote here was:
"PSGAGS also contributes to cartilage healing by providing the body with the building blocks of cartilage."
As a final example I give you my recent James Bond Piece with this illustrative and eye opening quote in terms of DMOAD potential:
" NaPPS resulted in significant improvement in clinical signs and articular cartilage healing, and no adverse effects were detected confirming that NaPPS has disease-modifying properties"
Pool-Boss, there have been a few examples of other research I have come across over the months that have come to the conclusion of DMOAD properties and hints of our magical iPPS wonder drug.
DYOR
- Forums
- ASX - By Stock
- PAR
- Trial PAR008 is on ANZCTR
Trial PAR008 is on ANZCTR, page-14
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $103.1M |
Open | High | Low | Value | Volume |
31.0¢ | 31.5¢ | 29.0¢ | $161.3K | 527.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10756 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 62010 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10756 | 0.300 |
1 | 99965 | 0.295 |
5 | 87991 | 0.290 |
3 | 38593 | 0.285 |
3 | 110000 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 62010 | 3 |
0.320 | 45000 | 2 |
0.325 | 50366 | 4 |
0.330 | 125773 | 4 |
0.335 | 10000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online